Clinical Trial

Liver Cancer Registry Platform

Study acronym: JADE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-08-10; most recent amendment 2026-06-03.
Status change: Not Yet Recruiting → Recruiting 2020-08-19
Trial Details
NCT Number NCT04510740
Lead Sponsor iOMEDICO AG
Conditions Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Enrollment 1,000 participants
Start Date 2020-08-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-04